Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hospital Samaritano is a premier private healthcare institution in Brazil, recognized for its high-complexity medical services and clinical excellence. Founded in 1894 in São Paulo, it has evolved into a prominent network with multiple units in São Paulo and Rio de Janeiro, including the flagship Samaritano Higienópolis. The hospital specializes in advanced therapeutic areas such as cardiology, oncology, neurology, orthopedics, and transplant surgery, and is accredited by the Joint Commission International (JCI). After being acquired by UnitedHealth Group in 2015, it was recently sold in 2024 as part of the Amil and Americas Serviços de Saúde group to Brazilian entrepreneur José Seripieri Filho. It remains one of the most technologically advanced and prestigious hospitals in Latin America, consistently ranking high in regional and global healthcare assessments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hospital Samaritano.